Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-03-19
1984-10-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546155, 546156, 544 94, 560 19, 560 44, 562458, 564199, 564414, 548485, 548486, A61K 3147, C07D21522
Patent
active
044761325
ABSTRACT:
Quinolinone derivatives of the formula (I) ##STR1## in which X represents oxy or a direct bond, R.sub.1 represents an aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic or heterocyclic-aliphatic radical or hydrogen, Ph represents an optionally additionally substituted 1,2-phenylene radical containing the group R.sub.1 --X--C(O)--, and one of the radicals R.sub.2 and R.sub.3 represents an optionally esterified or amidated carboxy group R.sub.4 and the other represents hydrogen or an aliphatic radical or, in the case of a radical R.sub.3, hydroxy, and in which either R.sub.A and R.sub.B together represent oxo, R.sub.C and R.sub.D together represent an additional bond, or, when R.sub.2 represents a radical R.sub.4, R.sub.C is hydrogen and R.sub.3 and R.sub.D together represent oxo, and R.sub.E represents a radical R.sub.5 which represents hydrogen or an aliphatic, cycloaliphatic, araliphatic heterocyclic-aliphatic radical, or R.sub.A represents an optionally etherified hydroxy group and R.sub.B together with R.sub.C and also R.sub.D together with R.sub.E represent an additional bond in each case, or, when R.sub.2 represents a radical R.sub.4, R.sub.B and R.sub.C together represent an additional bond and R.sub.3 and R.sub.D together represent oxo and R.sub.E represents a radical R.sub.5, and their salts, have antiallergic properties. They are manufactured, for example, by subjecting a compound of the formula (IV) ##STR2## in which Z represents a removable radical, or a tautomer and/or salt thereof, to intramolecular cyclisation.
REFERENCES:
patent: 3496184 (1970-02-01), Mizzoni et al.
patent: 3830817 (1974-08-01), Narayanan
patent: 4086349 (1978-04-01), Morinaka et al.
patent: 4119720 (1978-10-01), Hardtmann
patent: 4186201 (1980-01-01), Erickson
patent: 4187309 (1980-02-01), Hardtmann
patent: 4190659 (1980-02-01), Hardtmann
patent: 4223137 (1980-09-01), Yoshizaki et al.
Hall et al., J. Med. Chem., 17(7), pp. 685-690 (1974).
Mizzoni et al., Chemical Abstracts, vol. 73, 87757f (1970).
Hermans et al., Chemical Abstracts, vol. 74, 99901g (1971).
Murakami et al., Chemical Abstracts, vol. 80, 70803q (1974).
Kametani et al., Chemical Abstracts, vol. 90, 22775s (1979).
Kigasawa et al. Chemical Abstracts, vol. 92, 128747r (1980).
Koga et al., Chemical Abstracts, vol. 93, 198382n (1980).
Erickson et al., J. Med. Chem. 21 (9), pp. 984-988 (1978).
Germany 1,908,548, 11/05/70, Abstract.
Ferrini Pier G.
Goschke Richard
Sallmann Alfred
Ciba-Geigy Corporation
Daus Donald G.
Feit Irving N.
Glynn Michael W.
Rivers Diana G.
LandOfFree
Acylquinolinone derivatives, and antiallergic preparations and m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylquinolinone derivatives, and antiallergic preparations and m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylquinolinone derivatives, and antiallergic preparations and m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1600120